Ansätze und Methoden der ökonomischen Evaluation - Bad Request
Ansätze und Methoden der ökonomischen Evaluation - Bad Request
Ansätze und Methoden der ökonomischen Evaluation - Bad Request
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
108<br />
Län<strong>der</strong>bericht USA <strong>und</strong> Kanada<br />
• A clinical and economical evaluation of selective Serotonin reuptake inhibitors in major<br />
depression<br />
• Macrolides in community-acquires pneumonia and otitis media<br />
• An economic analysis of Sumatriptan for acute migraine<br />
• The efficacy of Tacrine and the measurement of outcomes in Alzheimer’s disease<br />
• Pharmacoeconomic evaluations of Clozapine in treatment-resistant schizophrenia and<br />
Risperidone in chronic Schizophrenia<br />
• Pulmozyme: Clinical and economic impacts<br />
• Finasteride: Clinical and economic impacts<br />
• Pharmaceutical management of peptic ulcer disease<br />
• Pharmaceutical management of gastroesophageal reflux disease<br />
• The use of nitrates in chronic stable angina<br />
• Interferon Beta 1-B and multiple sclerosis<br />
• Leukoreduction: The techniques used, their effectiveness and costs<br />
• HMG-CoA Reductase Inhibitors<br />
• SSRIs Part I: Clinical <strong>Evaluation</strong><br />
• SSRIs Part II: Cost-effectiveness<br />
• Assessment of techniques for cervical cancer screening<br />
• Coronary stents: Clinical experience and cost-effectiveness<br />
• A comparison of fixed and mobile CT and MRI scanners<br />
• Cost-effectiveness and cost-utility analyses of Finasteride therapy for the treatment of<br />
benign prostatic hyperplasia<br />
• Transcutanous electric nerve stimulation (TENS) and pain management<br />
• The treatment of obstructive sleep apnea: An Overview<br />
• A guidance document for the costing process (Version 1.0 1996)<br />
• Guidelines for the economic evaluation of pharmaceutical: Canada (2nd ed. 1997)<br />
• Selected health technologies in Canada (Issue 5.5 1996)<br />
• Reuse of disposable medical devices: Proceedings<br />
• Troglitazone for Type II Diabetes<br />
• Abdominal Aortic Aneurysm<br />
• Gallstone Therapies (1991)<br />
• A survey of investigational new drug and emergency drug release policies (1991)<br />
• An annotated bibliography of costs and benefits of prenatal screening programs (1991)<br />
• Exosurf neonatal for surfactant replacement therapy (1991)<br />
• Chiropractic treatment: A review of selected studies (1992)<br />
• An overview of the major breast screening studies and their findings (1992)<br />
• Influence of educational interventions on the test or<strong>der</strong>ing patterns of physicians (1992)<br />
• Endovascular coronary stents (Technology brief 1992)<br />
• The excimer laser (Technology brief 1992)<br />
• Steriotactic radiosurgery (Technology brief 1992)<br />
• Thrombolytic therapy: Current status (Technology brief 1992)<br />
• An international inventory of health care technology assessment reports and projects (1992)<br />
• Technology Assessment: National and International perspectives on research and practice.<br />
Summary and proceedings, June 13 1992<br />
• Magnetic field strength issues in magnetic resonance imaging (MRI) (1993)<br />
• Chelation therapy and atherosclerotic coronary artery disease (Technology brief 1993)<br />
CHEPA <strong>und</strong> CEM<br />
Ausgewählte laufende Projekte einzelner Mitglie<strong>der</strong> von CHEPA <strong>und</strong> CEM, Stand<br />
Mitte 1998:
Change language